|
Dec 18
|
Alkermes' Commitment to Integrity and Compliance
|
|
Dec 14
|
Alkermes' Culture of Employee Engagement and Wellness
|
|
Dec 14
|
Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk
|
|
Dec 13
|
12 Best Growth Stocks to Buy According to Billionaire Ray Dalio’s Bridgewater Associates
|
|
Dec 11
|
Patient Advocacy and Community Engagement at Alkermes
|
|
Dec 1
|
Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
|
|
Nov 29
|
Pharmaceuticals in the Environment
|
|
Nov 8
|
Environmental Health and Safety at Alkermes
|
|
Nov 7
|
Alkermes to Participate in the Jefferies London Healthcare Conference
|
|
Nov 4
|
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
|
|
Oct 19
|
Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
|
|
Oct 18
|
Alkermes (ALKS) Dips More Than Broader Market: What You Should Know
|
|
Oct 18
|
Alkermes to Report Third Quarter Financial Results on October 25, 2023
|
|
Aug 9
|
Should Weakness in Alkermes plc's (NASDAQ:ALKS) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
|
|
Aug 4
|
Puma Biotech (PBYI) Q2 Earnings Beat, Nerlynx Sales Outperform
|
|
May 26
|
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
|
|
May 26
|
Alkermes (ALKS) Up 3.7% Since Last Earnings Report: Can It Continue?
|
|
May 25
|
Alkermes Files Definitive Proxy Statement and Issues Letter to Shareholders Detailing Business Execution That Has Driven Strong Performance and Delivered Shareholder Value
|
|
May 16
|
Alkermes Highlights Data From Psychiatry Portfolio at Spring 2023 Scientific Conferences
|